Millavelez, John Clarck T.

HRN: 28-75-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CEFTRIAXONE 1G (VIAL)
03/27/2026
04/02/2026
IV
1.2g
Q12
TYPHOID FEVER
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: